logo

For the Inventor, By the Inventor

Oakland, CA, United States of America

Gary S Ott

This inventor holds 23 USPTO granted patents and 1 published patent application and 3 EPO patents, primarily in Immunological Adjuvants. Top assignees: Chiron Corporation, Novartis Vaccines & Diagnostics, Gmbh, Dynavax Technologies Corporation. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary S Ott. Retrieved from https://idiyas.com/inventor/gary-s-ott

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 65.2

 

Average Co-Inventor Count = 4.0

ph-index = 13

Forward Citations = 712(Granted Patents)


Location History:

  • Livermore, CA (US) (2001 - 2002)
  • Oakland, CA (US) (1998 - 2020)

Company Filing History:

goldMedal9 out of 672 
 
Chiron Corporation
 patents
silverMedal9 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents
bronzeMedal4 out of 66 
 
Dynavax Technologies Corporation
 patents
4. 1 out of 3,978 
 
Novartis Ag
 patents

Years Active: 1998-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
TLR7/8 Agonist
Chimeric Compounds
Microemulsions
Microparticles
Transfection
Dendritic Cells
Adjuvant Compositions
Vaccine Formulations
Oil-in-Water Emulsions
Immune Responses
Antigen Stimulation
Macromolecules
23 patents (USPTO):Explore Patents
1. 10722591 - Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof (2020-07-28),
2. 10548975 - Branched chimeric compounds, and methods of use thereof (2020-02-04),
3. 10350290 - Linear chimeric compounds and methods of use thereof (2019-07-16),
4. 9950064 - Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof (2018-04-24),
5. 8771747 - Microemulsions with adsorbed macromolecules and microparticles (2014-07-08),
6. 8734832 - Microemulsions with adsorbed macromolecules and microparticles (2014-05-27),
7. 8309139 - Microemulsions with adsorbed macromolecules and microparticles (2012-11-13),
8. 8206749 - Microemulsions with adsorbed macromolecules and microparticles (2012-06-26),
9. 8097243 - Microparticle-based transfection and activation of dendritic cells (2012-01-17),
10. 8021834 - Use of microparticles combined with submicron oil-in-water emulsions (2011-09-20),
11. 7713739 - Microparticle-based transfection and activation of dendritic cells (2010-05-11),
12. 7641911 - Immunological adjuvant compositions (2010-01-05),
13. 7597908 - Use of microparticles with adsorbed antigen to stimulate immune responses (2009-10-06),
14. 7393630 - Use of microparticles combined with submicron oil-in-water emulsions (2008-07-01),
15. 6884435 - Microparticles with adsorbent surfaces, methods of making same, and uses thereof (2005-04-26),

Title: The Inventor Profile of Gary S Ott

Introduction: Gary S Ott is a prolific inventor based in Oakland, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Gary S Ott's most recent patents include innovative designs in the tech and healthcare sectors, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Gary S Ott has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them.

Collaborations: Throughout his career, Gary S Ott has collaborated with leading companies and research institutions to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Gary S Ott's passion for innovation and his dedication to pushing the boundaries of what is possible make him a standout figure in the world of inventors, with a legacy that is sure to inspire future generations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…